-
Something wrong with this record ?
Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation
P. Budera, P. Osmancik, D. Herman, J. Zdarska, D. Talavera, A. Mala, R. Prochazkova, Z. Straka,
Language English Country Netherlands
Document type Journal Article
Grant support
NV16-32478A
MZ0
CEP Register
Digital library NLK
Full text - Article
NLK
ProQuest Central
from 1997-07-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2011-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-07-01 to 1 year ago
- MeSH
- Equipment Safety MeSH
- Time Factors MeSH
- Chronic Disease MeSH
- Equipment Design MeSH
- Electrocardiography, Ambulatory methods MeSH
- Electrocardiography methods MeSH
- Atrial Fibrillation diagnostic imaging surgery MeSH
- Risk Assessment MeSH
- Catheter Ablation instrumentation methods MeSH
- Cohort Studies MeSH
- Middle Aged MeSH
- Humans MeSH
- Monitoring, Physiologic instrumentation methods MeSH
- Follow-Up Studies MeSH
- Recurrence MeSH
- Retrospective Studies MeSH
- Aged MeSH
- Severity of Illness Index MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
PURPOSE: Hybrid ablation of atrial fibrillation (AF) is a promising treatment strategy for patients with non-paroxysmal AF, although, data regarding mid-term outcomes are limited. METHODS: Patients with persistent or long-standing persistent AF were enrolled. Initially, a thoracoscopic, right-sided, epicardial ablation was performed, with a goal of creating a box lesion on the posterior wall of the left atrium; a novel versapolar radiofrequency (RF) catheter was used. In patients enrolled later, occlusion of the left atrial appendage was also performed. An endocardial procedure was performed 2-4 months later, with the goal of confirming/completing the box lesion and ablating the ganglionated plexi and cavotricuspid isthmus. Efficacy was assessed using multiple 24-h and 1-week Holter monitoring. Analysis was performed to search for variables associated with procedure's failure. RESULTS: Forty-one patients (14 persistent and 27 long-standing persistent AF) were enrolled with a mean AF duration of 33.5 ± 33.1 months. Mean follow-up was 507.2 ± 201.1 days (180-731). At the last follow-up visit, 27(65%) patients were arrhythmia-free, without anti-arrhythmics or need for re-ablation. Additional 4 patients (9.8%) were in sinus rhythm (SR) following re-ablation of postprocedural peri-mitral flutter and 4 (9.8%) were in SR on anti-arrhythmics. Longer periods of preoperative AF were independently associated with worse arrhythmia-free survival (p = 0.015). Serious postoperative complications occurred in 3 (7.3%) patients; only 1 (2.4%) patient had clinical consequences after 6 months. CONCLUSIONS: Hybrid ablation of non-paroxysmal AF using a novel, versapolar RF device yields promising mid-term results. Better arrhythmia-free survival rates were found in AF patients with shorter AF duration.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18033719
- 003
- CZ-PrNML
- 005
- 20181026114650.0
- 007
- ta
- 008
- 181008s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s10840-017-0286-y $2 doi
- 035 __
- $a (PubMed)28921386
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Budera, Petr $u Cardiocenter, Department of Cardiac Surgery, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- 245 10
- $a Midterm outcomes of two-staged hybrid ablation of persistent and long-standing persistent atrial fibrillation using the versapolar epicardial surgical device and subsequent catheter ablation / $c P. Budera, P. Osmancik, D. Herman, J. Zdarska, D. Talavera, A. Mala, R. Prochazkova, Z. Straka,
- 520 9_
- $a PURPOSE: Hybrid ablation of atrial fibrillation (AF) is a promising treatment strategy for patients with non-paroxysmal AF, although, data regarding mid-term outcomes are limited. METHODS: Patients with persistent or long-standing persistent AF were enrolled. Initially, a thoracoscopic, right-sided, epicardial ablation was performed, with a goal of creating a box lesion on the posterior wall of the left atrium; a novel versapolar radiofrequency (RF) catheter was used. In patients enrolled later, occlusion of the left atrial appendage was also performed. An endocardial procedure was performed 2-4 months later, with the goal of confirming/completing the box lesion and ablating the ganglionated plexi and cavotricuspid isthmus. Efficacy was assessed using multiple 24-h and 1-week Holter monitoring. Analysis was performed to search for variables associated with procedure's failure. RESULTS: Forty-one patients (14 persistent and 27 long-standing persistent AF) were enrolled with a mean AF duration of 33.5 ± 33.1 months. Mean follow-up was 507.2 ± 201.1 days (180-731). At the last follow-up visit, 27(65%) patients were arrhythmia-free, without anti-arrhythmics or need for re-ablation. Additional 4 patients (9.8%) were in sinus rhythm (SR) following re-ablation of postprocedural peri-mitral flutter and 4 (9.8%) were in SR on anti-arrhythmics. Longer periods of preoperative AF were independently associated with worse arrhythmia-free survival (p = 0.015). Serious postoperative complications occurred in 3 (7.3%) patients; only 1 (2.4%) patient had clinical consequences after 6 months. CONCLUSIONS: Hybrid ablation of non-paroxysmal AF using a novel, versapolar RF device yields promising mid-term results. Better arrhythmia-free survival rates were found in AF patients with shorter AF duration.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a fibrilace síní $x diagnostické zobrazování $x chirurgie $7 D001281
- 650 _2
- $a katetrizační ablace $x přístrojové vybavení $x metody $7 D017115
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a kohortové studie $7 D015331
- 650 _2
- $a elektrokardiografie $x metody $7 D004562
- 650 _2
- $a elektrokardiografie ambulantní $x metody $7 D015716
- 650 _2
- $a design vybavení $7 D004867
- 650 _2
- $a bezpečnost vybavení $7 D004869
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a monitorování fyziologických funkcí $x přístrojové vybavení $x metody $7 D008991
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a hodnocení rizik $7 D018570
- 650 _2
- $a stupeň závažnosti nemoci $7 D012720
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Osmancik, Pavel $u Cardiocenter, Department of Cardiology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Prague 10, Czech Republic. pavel.osmancik@gmail.com.
- 700 1_
- $a Herman, Dalibor $u Cardiocenter, Department of Cardiology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Prague 10, Czech Republic.
- 700 1_
- $a Zdarska, Jana $u Cardiocenter, Department of Cardiology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Prague 10, Czech Republic.
- 700 1_
- $a Talavera, David $u Cardiocenter, Department of Cardiac Surgery, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- 700 1_
- $a Mala, Anna $u Cardiocenter, Department of Cardiology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Prague 10, Czech Republic.
- 700 1_
- $a Prochazkova, Radka $u Cardiocenter, Department of Cardiology, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Srobarova 50, 100 34, Prague 10, Czech Republic.
- 700 1_
- $a Straka, Zbynek $u Cardiocenter, Department of Cardiac Surgery, 3rd Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, Czech Republic.
- 773 0_
- $w MED00008134 $t Journal of interventional cardiac electrophysiology an international journal of arrhythmias and pacing $x 1572-8595 $g Roč. 50, č. 2 (2017), s. 187-194
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28921386 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181026115201 $b ABA008
- 999 __
- $a ok $b bmc $g 1339565 $s 1030713
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 50 $c 2 $d 187-194 $e 20170918 $i 1572-8595 $m Journal of interventional cardiac electrophysiology $n J Interv Card Electrophysiol $x MED00008134
- GRA __
- $a NV16-32478A $p MZ0
- LZP __
- $a Pubmed-20181008